NETHERLANDS - Gilde leads $11m ProFibrix funding
Gilde Health Partners has led a $11m series-B financing round for biotechnology business ProFibrix BV, alongside existing investor Index Ventures.
Based in Leiden, ProFibrix was founded in 2004. The company develops and markets products for the hemostasis and regenerative medicine markets. The financing will be applied to the ongoing clinical development of lead product Fibrocaps, as well as to the preclinical development of pipeline products.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds
Back to Top








